BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen F, Wang T, Wu YF, Gu Y, Xu XL, Zheng S, Hu X. Honokiol: A potent chemotherapy candidate for human colorectal carcinoma. World J Gastroenterol 2004; 10(23): 3459-3463 [PMID: 15526365 DOI: 10.3748/wjg.v10.i23.3459] [Cited by in CrossRef: 98] [Cited by in F6Publishing: 101] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Khatoon F, Ali S, Kumar V, Elasbali AM, Alhassan HH, Alharethi SH, Islam A, Hassan MI. Pharmacological features, health benefits and clinical implications of honokiol. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2120541] [Reference Citation Analysis]
2 Ezzeldeen Y, Swidan S, ElMeshad A, Sebak A. Green Synthesized Honokiol Transfersomes Relieve the Immunosuppressive and Stem-Like Cell Characteristics of the Aggressive B16F10 Melanoma. Int J Nanomedicine 2021;16:5693-712. [PMID: 34465990 DOI: 10.2147/IJN.S314472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Wang T, Wang H, Yang F, Gao K, Luo S, Bai L, Ma K, Liu M, Wu S, Wang H, Chen Z, Xiao Q. Honokiol inhibits proliferation of colorectal cancer cells by targeting anoctamin 1/TMEM16A Ca2+ -activated Cl- channels. Br J Pharmacol 2021. [PMID: 34192810 DOI: 10.1111/bph.15606] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Mohassab AM, Hassan HA, Abdelhamid D, Abdel-Aziz M. STAT3 transcription factor as target for anti-cancer therapy. Pharmacol Rep 2020;72:1101-24. [PMID: 32880101 DOI: 10.1007/s43440-020-00156-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
5 Yan Y, Xu J, Mao G. Honokiol Suppression of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastric Cancer Cell Biological Activity and Its Mechanism. Med Sci Monit 2020;26:e923962. [PMID: 32862190 DOI: 10.12659/MSM.923962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Ong CP, Lee WL, Tang YQ, Yap WH. Honokiol: A Review of Its Anticancer Potential and Mechanisms. Cancers (Basel) 2019;12:E48. [PMID: 31877856 DOI: 10.3390/cancers12010048] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 21.3] [Reference Citation Analysis]
7 Lin D, Yan Z, Chen A, Ye J, Hu A, Liu J, Peng J, Wu X. Anti-proliferative activity and structure-activity relationship of honokiol derivatives. Bioorg Med Chem 2019;27:3729-34. [PMID: 31278004 DOI: 10.1016/j.bmc.2019.06.042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
8 Banik K, Ranaware AM, Deshpande V, Nalawade SP, Padmavathi G, Bordoloi D, Sailo BL, Shanmugam MK, Fan L, Arfuso F, Sethi G, Kunnumakkara AB. Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets. Pharmacological Research 2019;144:192-209. [DOI: 10.1016/j.phrs.2019.04.004] [Cited by in Crossref: 93] [Cited by in F6Publishing: 87] [Article Influence: 31.0] [Reference Citation Analysis]
9 Luo H, Wu H, Yu X, Zhang X, Lu Y, Fan J, Tang L, Wang Z. A review of the phytochemistry and pharmacological activities of Magnoliae officinalis cortex. J Ethnopharmacol 2019;236:412-42. [PMID: 30818008 DOI: 10.1016/j.jep.2019.02.041] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 11.7] [Reference Citation Analysis]
10 Rauf A, Patel S, Imran M, Maalik A, Arshad MU, Saeed F, Mabkhot YN, Al-showiman SS, Ahmad N, Elsharkawy E. Honokiol: An anticancer lignan. Biomedicine & Pharmacotherapy 2018;107:555-62. [DOI: 10.1016/j.biopha.2018.08.054] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 10.8] [Reference Citation Analysis]
11 Ranaware AM, Banik K, Deshpande V, Padmavathi G, Roy NK, Sethi G, Fan L, Kumar AP, Kunnumakkara AB. Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer. Int J Mol Sci 2018;19:E2362. [PMID: 30103472 DOI: 10.3390/ijms19082362] [Cited by in Crossref: 86] [Cited by in F6Publishing: 91] [Article Influence: 21.5] [Reference Citation Analysis]
12 Dai X, Li RZ, Jiang ZB, Wei CL, Luo LX, Yao XJ, Li GP, Leung EL. Honokiol Inhibits Proliferation, Invasion and Induces Apoptosis Through Targeting Lyn Kinase in Human Lung Adenocarcinoma Cells. Front Pharmacol 2018;9:558. [PMID: 29892225 DOI: 10.3389/fphar.2018.00558] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
13 Song JM, Anandharaj A, Upadhyaya P, Kirtane AR, Kim JH, Hong KH, Panyam J, Kassie F. Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors. Oncotarget 2016;7:57752-69. [PMID: 27458163 DOI: 10.18632/oncotarget.10759] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
14 Huang K, Chen Y, Zhang R, Wu Y, Ma Y, Fang X, Shen S. Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo. Cell Death Dis 2018;9:157. [PMID: 29410403 DOI: 10.1038/s41419-017-0166-5] [Cited by in Crossref: 64] [Cited by in F6Publishing: 78] [Article Influence: 16.0] [Reference Citation Analysis]
15 Shubin AV, Demidyuk IV, Komissarov AA, Rafieva LM, Kostrov SV. Cytoplasmic vacuolization in cell death and survival. Oncotarget 2016;7:55863-89. [PMID: 27331412 DOI: 10.18632/oncotarget.10150] [Cited by in Crossref: 148] [Cited by in F6Publishing: 154] [Article Influence: 37.0] [Reference Citation Analysis]
16 Yang J, Zou Y, Jiang D. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells. Int J Mol Med 2018;41:1845-54. [PMID: 29393336 DOI: 10.3892/ijmm.2018.3433] [Cited by in Crossref: 15] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
17 Huang KJ, Kuo CH, Chen SH, Lin CY, Lee YR. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy. J Cell Mol Med 2018;22:1894-908. [PMID: 29363886 DOI: 10.1111/jcmm.13474] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
18 Poivre M, Duez P. Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents. J Zhejiang Univ Sci B 2017;18:194-214. [PMID: 28271656 DOI: 10.1631/jzus.B1600299] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 10.6] [Reference Citation Analysis]
19 Godugu C, Doddapaneni R, Singh M. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC). Colloids Surf B Biointerfaces 2017;153:208-19. [PMID: 28249200 DOI: 10.1016/j.colsurfb.2017.01.038] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
20 Gowda AS, Suo Z, Spratt TE. Honokiol Inhibits DNA Polymerases β and λ and Increases Bleomycin Sensitivity of Human Cancer Cells. Chem Res Toxicol 2017;30:715-25. [PMID: 28067485 DOI: 10.1021/acs.chemrestox.6b00451] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
21 Guillermo-Lagae R, Santha S, Thomas M, Zoelle E, Stevens J, Kaushik RS, Dwivedi C. Antineoplastic Effects of Honokiol on Melanoma. Biomed Res Int 2017;2017:5496398. [PMID: 28194418 DOI: 10.1155/2017/5496398] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
22 Shi X, Yang L, Gao J, Sheng Y, Li X, Gu Y, Zhuang G, Chen F. Deep sequencing of Magnoliae officinalis reveals upstream genes related to the lignan biosynthetic pathway. J For Res 2017;28:671-81. [DOI: 10.1007/s11676-016-0356-5] [Reference Citation Analysis]
23 Pan J, Lee Y, Zhang Q, Xiong D, Wan TC, Wang Y, You M. Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway. Cancer Prev Res (Phila) 2017;10:133-41. [PMID: 27849557 DOI: 10.1158/1940-6207.CAPR-16-0129] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 5.2] [Reference Citation Analysis]
24 Mędra A, Witkowska M, Majchrzak A, Cebula-Obrzut B, Bonner MY, Robak T, Arbiser JL, Smolewski P. Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies. Molecules 2016;21:E995. [PMID: 27483232 DOI: 10.3390/molecules21080995] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
25 Hahm ER, Singh KB, Singh SV. c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells. Cell Cycle 2016;15:2309-20. [PMID: 27341160 DOI: 10.1080/15384101.2016.1201253] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
26 Bahmani M, Shirzad H, Shahinfard N, Sheivandi L, Rafieian-Kopaei M. Cancer Phytotherapy: Recent Views on the Role of Antioxidant and Angiogenesis Activities. J Evid Based Complementary Altern Med 2017;22:299-309. [PMID: 26753686 DOI: 10.1177/2156587215625157] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
27 Pan J, Lee Y, Wang Y, You M. Honokiol targets mitochondria to halt cancer progression and metastasis. Mol Nutr Food Res 2016;60:1383-95. [DOI: 10.1002/mnfr.201501007] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 5.5] [Reference Citation Analysis]
28 McCulloch M, Ly H, Broffman M, See C, Clemons J, Chang R. Chinese Herbal Medicine and Fluorouracil-Based Chemotherapy for Colorectal Cancer: A Quality-Adjusted Meta-Analysis of Randomized Controlled Trials. Integr Cancer Ther 2016;15:285-307. [PMID: 27151587 DOI: 10.1177/1534735416638738] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
29 Wang Y, Yu RY, He QY. Proteomic Analysis of Anticancer TCMs Targeted at Mitochondria. Evid Based Complement Alternat Med 2015;2015:539260. [PMID: 26568766 DOI: 10.1155/2015/539260] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
30 Fang CY, Chen SJ, Wu HN, Ping YH, Lin CY, Shiuan D, Chen CL, Lee YR, Huang KJ. Honokiol, a Lignan Biphenol Derived from the Magnolia Tree, Inhibits Dengue Virus Type 2 Infection. Viruses 2015;7:4894-910. [PMID: 26378567 DOI: 10.3390/v7092852] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 6.0] [Reference Citation Analysis]
31 Seo MS, Kim JH, Kim HJ, Chang KC, Park SW. Honokiol activates the LKB1–AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes. Toxicology and Applied Pharmacology 2015;284:113-24. [DOI: 10.1016/j.taap.2015.02.020] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 7.9] [Reference Citation Analysis]
32 Ovadje P, Roma A, Steckle M, Nicoletti L, Arnason JT, Pandey S. Advances in the research and development of natural health products as main stream cancer therapeutics. Evid Based Complement Alternat Med 2015;2015:751348. [PMID: 25883673 DOI: 10.1155/2015/751348] [Cited by in Crossref: 27] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
33 Kaushik G, Venugopal A, Ramamoorthy P, Standing D, Subramaniam D, Umar S, Jensen RA, Anant S, Mammen JM. Honokiol inhibits melanoma stem cells by targeting notch signaling. Mol Carcinog 2015;54:1710-21. [PMID: 25491779 DOI: 10.1002/mc.22242] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 6.5] [Reference Citation Analysis]
34 Coppola M, Mondola R. Potential use of Magnolia officinalis bark polyphenols in the treatment of cannabis dependence. Med Hypotheses 2014;83:673-6. [PMID: 25459131 DOI: 10.1016/j.mehy.2014.09.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
35 Kaushik G, Kwatra D, Subramaniam D, Jensen RA, Anant S, Mammen JM. Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway. Am J Surg 2014;208:995-1002; discussion 1001-2. [PMID: 25450590 DOI: 10.1016/j.amjsurg.2014.09.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
36 Saeed M, Kuete V, Kadioglu O, Börtzler J, Khalid H, Greten HJ, Efferth T. Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking. Phytomedicine 2014;21:1525-33. [DOI: 10.1016/j.phymed.2014.07.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
37 Liang WZ, Chou CT, Chang HT, Cheng JS, Kuo DH, Ko KC, Chiang NN, Wu RF, Shieh P, Jan CR. The mechanism of honokiol-induced intracellular Ca(2+) rises and apoptosis in human glioblastoma cells. Chem Biol Interact 2014;221:13-23. [PMID: 25106108 DOI: 10.1016/j.cbi.2014.07.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
38 Hahm ER, Sakao K, Singh SV. Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells. Prostate 2014;74:1209-21. [PMID: 25043291 DOI: 10.1002/pros.22837] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 6.6] [Reference Citation Analysis]
39 Dong Y, Tang M, Song H, Li R, Wang C, Ye H, Qiu N, Zhang Y, Chen L, Wei Y. Characterization of metabolic profile of honokiol in rat feces using liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry and 13C stable isotope labeling. Journal of Chromatography B 2014;953-954:20-9. [DOI: 10.1016/j.jchromb.2014.01.047] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
40 Aghamohammadi A, Hosseinimehr SJ. Antiangiogenic Agents in Natural Products for the Treatment of Gynecologic Disorders. Nutrition and Cancer 2013;66:206-13. [DOI: 10.1080/01635581.2014.865136] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
41 Averett C, Arora S, Zubair H, Singh S, Bhardwaj A, Singh AP. Molecular Targets of Honokiol: A Promising Phytochemical for Effective Cancer Management. Enzymes 2014;36:175-93. [PMID: 27102704 DOI: 10.1016/B978-0-12-802215-3.00009-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
42 Hahm ER, Karlsson AI, Bonner MY, Arbiser JL, Singh SV. Honokiol inhibits androgen receptor activity in prostate cancer cells. Prostate 2014;74:408-20. [PMID: 24338950 DOI: 10.1002/pros.22762] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
43 Sun W, Lv C, Zhu T, Yang X, Wei S, Sun J, Hong K, Zhu W, Huang C. Ophiobolin-O reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human breast carcinoma (MCF-7/ADR) cells. Mar Drugs 2013;11:4570-84. [PMID: 24240979 DOI: 10.3390/md11114570] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
44 Kumar A, Kumar Singh U, Chaudhary A. Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities. Future Med Chem 2013;5:809-29. [PMID: 23651094 DOI: 10.4155/fmc.13.32] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
45 Woodbury A, Yu SP, Wei L, García P. Neuro-modulating effects of honokiol: a review. Front Neurol 2013;4:130. [PMID: 24062717 DOI: 10.3389/fneur.2013.00130] [Cited by in Crossref: 82] [Cited by in F6Publishing: 90] [Article Influence: 9.1] [Reference Citation Analysis]
46 Chang KH, Yan MD, Yao CJ, Lin PC, Lai GM. Honokiol-induced apoptosis and autophagy in glioblastoma multiforme cells. Oncol Lett 2013;6:1435-8. [PMID: 24179537 DOI: 10.3892/ol.2013.1548] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 5.1] [Reference Citation Analysis]
47 Lee NJ, Oh JH, Ban JO, Shim JH, Lee HP, Jung JK, Ahn BW, Yoon DY, Han SB, Ham YW, Hong JT. 4-O-methylhonokiol, a PPARγ agonist, inhibits prostate tumour growth: p21-mediated suppression of NF-κB activity. Br J Pharmacol 2013;168:1133-45. [PMID: 23043610 DOI: 10.1111/j.1476-5381.2012.02235.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
48 Zbidah M, Lupescu A, Herrmann T, Yang W, Foller M, Jilani K, Lang F. Effect of honokiol on erythrocytes. Toxicol In Vitro 2013;27:1737-45. [PMID: 23673313 DOI: 10.1016/j.tiv.2013.05.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
49 Yao CJ, Lai GM, Yeh CT, Lai MT, Shih PH, Chao WJ, Whang-Peng J, Chuang SE, Lai TY. Honokiol Eliminates Human Oral Cancer Stem-Like Cells Accompanied with Suppression of Wnt/ β -Catenin Signaling and Apoptosis Induction. Evid Based Complement Alternat Med 2013;2013:146136. [PMID: 23662112 DOI: 10.1155/2013/146136] [Cited by in Crossref: 28] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
50 Singh T, Katiyar SK. Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE₂-mediated activation of β-catenin signaling. PLoS One 2013;8:e60749. [PMID: 23580348 DOI: 10.1371/journal.pone.0060749] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 6.3] [Reference Citation Analysis]
51 Singh T, Prasad R, Katiyar SK. Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo. Epigenetics 2013;8:54-65. [PMID: 23221619 DOI: 10.4161/epi.23078] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 4.6] [Reference Citation Analysis]
52 Ishikawa C, Arbiser JL, Mori N. Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia. Biochimica et Biophysica Acta (BBA) - General Subjects 2012;1820:879-87. [DOI: 10.1016/j.bbagen.2012.03.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
53 Yu C, Zhang Q, Zhang HY, Zhang X, Huo X, Cheng E, Wang DH, Arbiser JL, Spechler SJ, Souza RF. Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett's cells. Am J Physiol Gastrointest Liver Physiol 2012;303:G561-9. [PMID: 22744336 DOI: 10.1152/ajpgi.00033.2012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
54 Rajendran P, Li F, Shanmugam MK, Vali S, Abbasi T, Kapoor S, Ahn KS, Kumar AP, Sethi G. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1. J Cell Physiol 2012;227:2184-95. [PMID: 21792937 DOI: 10.1002/jcp.22954] [Cited by in Crossref: 120] [Cited by in F6Publishing: 124] [Article Influence: 12.0] [Reference Citation Analysis]
55 Zuo Y, Yu Y, Wang S, Shao W, Zhou B, Lin L, Luo Z, Huang R, Du J, Bu X. Synthesis and cytotoxicity evaluation of biaryl-based chalcones and their potential in TNFα-induced nuclear factor-κB activation inhibition. European Journal of Medicinal Chemistry 2012;50:393-404. [DOI: 10.1016/j.ejmech.2012.02.023] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
56 Chen Y, Hsiao P, Lin F, Wu G, Tsai C. Evidence-based Anticancer Materia Medica for Prostate Cancer. Materia Medica for Various Cancers 2012. [DOI: 10.1007/978-94-007-1983-5_6] [Reference Citation Analysis]
57 Chilampalli C, Guillermo R, Kaushik RS, Young A, Chandrasekher G, Fahmy H, Dwivedi C. Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells. Exp Biol Med (Maywood) 2011;236:1351-9. [DOI: 10.1258/ebm.2011.011030] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
58 Steinmann P, Walters DK, Arlt MJ, Banke IJ, Ziegler U, Langsam B, Arbiser J, Muff R, Born W, Fuchs B. Antimetastatic activity of honokiol in osteosarcoma. Cancer 2012;118:2117-27. [PMID: 21935912 DOI: 10.1002/cncr.26434] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
59 Ramsay EE, Hogg PJ, Dilda PJ. Mitochondrial metabolism inhibitors for cancer therapy. Pharm Res. 2011;28:2731-2744. [PMID: 21918915 DOI: 10.1007/s11095-011-0584-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
60 Ma L, Chen J, Wang X, Liang X, Luo Y, Zhu W, Wang T, Peng M, Li S, Jie S, Peng A, Wei Y, Chen L. Structural Modification of Honokiol, a Biphenyl Occurring in Magnolia officinalis: the Evaluation of Honokiol Analogues as Inhibitors of Angiogenesis and for Their Cytotoxicity and Structure–Activity Relationship. J Med Chem 2011;54:6469-81. [DOI: 10.1021/jm200830u] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 4.4] [Reference Citation Analysis]
61 Lan KH, Wang YW, Lee WP, Lan KL, Tseng SH, Hung LR, Yen SH, Lin HC, Lee SD. Multiple effects of Honokiol on the life cycle of hepatitis C virus. Liver Int. 2012;32:989-997. [PMID: 22098176 DOI: 10.1111/j.1478-3231.2011.02621.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
62 He Z, Subramaniam D, Ramalingam S, Dhar A, Postier RG, Umar S, Zhang Y, Anant S. Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects. Am J Physiol Gastrointest Liver Physiol 2011;301:G929-37. [PMID: 21836060 DOI: 10.1152/ajpgi.00159.2011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
63 Oh JH, Ban JO, Cho MC, Jo M, Jung JK, Ahn B, Yoon DY, Han SB, Hong JT. 4-O-methylhonokiol inhibits colon tumor growth via p21-mediated suppression of NF-κB activity. J Nutr Biochem 2012;23:706-15. [PMID: 21820300 DOI: 10.1016/j.jnutbio.2011.03.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
64 Arora S, Bhardwaj A, Srivastava SK, Singh S, McClellan S, Wang B, Singh AP. Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells. PLoS One 2011;6:e21573. [PMID: 21720559 DOI: 10.1371/journal.pone.0021573] [Cited by in Crossref: 102] [Cited by in F6Publishing: 103] [Article Influence: 9.3] [Reference Citation Analysis]
65 Lan K, Lan K, Sheu M, Chen M, Shih Y, Hsu F, Wang H, Liu R, Yen S. Honokiol inhibits hypoxia-inducible factor-1 pathway. International Journal of Radiation Biology 2011;87:579-90. [DOI: 10.3109/09553002.2011.568572] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
66 Lee YJ, Lee YM, Lee CK, Jung JK, Han SB, Hong JT. Therapeutic applications of compounds in the Magnolia family. Pharmacol Ther. 2011;130:157-176. [PMID: 21277893 DOI: 10.1016/j.pharmthera.2011.01.010] [Cited by in Crossref: 287] [Cited by in F6Publishing: 270] [Article Influence: 26.1] [Reference Citation Analysis]
67 Munroe ME, Businga TR, Kline JN, Bishop GA. Anti-inflammatory effects of the neurotransmitter agonist Honokiol in a mouse model of allergic asthma. J Immunol 2010;185:5586-97. [PMID: 20889543 DOI: 10.4049/jimmunol.1000630] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 4.4] [Reference Citation Analysis]
68 Li H, Wang X, Hu Y. Distinct photoacidity of honokiol from magnolol. J Fluoresc 2011;21:265-73. [PMID: 20814723 DOI: 10.1007/s10895-010-0714-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
69 Chen G, Wang F, Trachootham D, Huang P. Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds. Mitochondrion 2010;10:614-25. [PMID: 20713185 DOI: 10.1016/j.mito.2010.08.001] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 5.8] [Reference Citation Analysis]
70 Leeman-Neill RJ, Cai Q, Joyce SC, Thomas SM, Bhola NE, Neill DB, Arbiser JL, Grandis JR. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors. Clin Cancer Res 2010;16:2571-9. [PMID: 20388852 DOI: 10.1158/1078-0432.CCR-10-0333] [Cited by in Crossref: 74] [Cited by in F6Publishing: 78] [Article Influence: 6.2] [Reference Citation Analysis]
71 Sagar SM, Wong RK. Increasing Therapeutic Gain and Controlling Radiation-Induced Injuries with Asian Botanicals and Acupuncture. Supportive Cancer Care with Chinese Medicine 2010. [DOI: 10.1007/978-90-481-3555-4_6] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
72 Vassão DG, Kim K, Davin LB, Lewis NG. Lignans (Neolignans) and Allyl/Propenyl Phenols: Biogenesis, Structural Biology, and Biological/Human Health Considerations. Comprehensive Natural Products II. Elsevier; 2010. pp. 815-928. [DOI: 10.1016/b978-008045382-8.00001-0] [Cited by in Crossref: 13] [Article Influence: 1.1] [Reference Citation Analysis]
73 Yuan Z, Liu H, Yan F, Wang Y, Gou L, Nie C, Ding Z, Lai S, Zhao Y, Zhao X, Li J, Deng H, Mao Y, Chen L, Wei Y, Zhao X. Improved therapeutic efficacy against murine carcinoma by combining honokiol with gene therapy of PNAS-4, a novel pro-apoptotic gene. Cancer Science 2009;100:1757-66. [DOI: 10.1111/j.1349-7006.2009.01242.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
74 Hu J, Chen LJ, Liu L, Chen X, Chen PL, Yang G, Hou WL, Tang MH, Zhang F, Wang XH. Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity. Exp Mol Med. 2008;40:617-628. [PMID: 19116447 DOI: 10.3858/emm.2008.40.6.617] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 3.2] [Reference Citation Analysis]
75 Han LL, Xie LP, Li LH, Zhang XW, Zhang RQ, Wang HZ. Reactive oxygen species production and Bax/Bcl-2 regulation in honokiol-induced apoptosis in human hepatocellular carcinoma SMMC-7721 cells. Environ Toxicol Pharmacol 2009;28:97-103. [PMID: 21783988 DOI: 10.1016/j.etap.2009.03.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
76 Ainbinder D, Protokin R, Chaouat M, Touitou E. Effect of honokiol and 5-FU on non-melanoma skin cancer cells. Journal of Drug Delivery Science and Technology 2009;19:283-7. [DOI: 10.1016/s1773-2247(09)50053-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
77 Raja SM, Chen S, Yue P, Acker TM, Lefkove B, Arbiser JL, Khuri FR, Sun SY. The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis. Mol Cancer Ther 2008;7:2212-23. [PMID: 18645030 DOI: 10.1158/1535-7163.MCT-07-2409] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
78 Lee SK, Kim HN, Kang YR, Lee CW, Kim HM, Han DC, Shin J, Bae K, Kwon BM. Obovatol inhibits colorectal cancer growth by inhibiting tumor cell proliferation and inducing apoptosis. Bioorg Med Chem. 2008;16:8397-8402. [PMID: 18762427 DOI: 10.1016/j.bmc.2008.08.033] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
79 Hou W, Chen L, Yang G, Zhou H, Jiang Q, Zhong Z, Hu J, Chen X, Wang X, Yuan Y, Tang M, Wen J, Wei Y. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models. Phytother Res 2008;22:1125-32. [DOI: 10.1002/ptr.2472] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.7] [Reference Citation Analysis]
80 Li Z, Liu Y, Zhao X, Pan X, Yin R, Huang C, Chen L, Wei Y. Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells. Eur J Obstet Gynecol Reprod Biol 2008;140:95-102. [PMID: 18440692 DOI: 10.1016/j.ejogrb.2008.02.023] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.6] [Reference Citation Analysis]
81 Lee SY, Yuk DY, Song HS, Yoon DY, Jung JK, Moon DC, Lee BS, Hong JT. Growth inhibitory effects of obovatol through induction of apoptotic cell death in prostate and colon cancer by blocking of NF-κB. European Journal of Pharmacology 2008;582:17-25. [DOI: 10.1016/j.ejphar.2007.12.027] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
82 Ling B, Liang S, Xu Y, Zhao X, Tang M, Liu X, Zhao X, Huang C, Chen L, Wei Y. Differential proteomic analysis of HeLa cells treated with Honokiol using a quantitative proteomic strategy. Amino Acids 2008;35:115-22. [DOI: 10.1007/s00726-007-0615-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
83 Liu Y, Chen L, He X, Fan L, Yang G, Chen X, Lin X, DU L, Li Z, Ye H, Mao Y, Zhao X, Wei Y. Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma. Int J Gynecol Cancer 2008;18:652-9. [PMID: 17892458 DOI: 10.1111/j.1525-1438.2007.01070.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
84 Munroe ME, Arbiser JL, Bishop GA. Honokiol, a Natural Plant Product, Inhibits Inflammatory Signals and Alleviates Inflammatory Arthritis. J Immunol 2007;179:753-63. [DOI: 10.4049/jimmunol.179.2.753] [Cited by in Crossref: 86] [Cited by in F6Publishing: 89] [Article Influence: 5.7] [Reference Citation Analysis]
85 Shigemura K, Arbiser JL, Sun SY, Zayzafoon M, Johnstone PA, Fujisawa M, Gotoh A, Weksler B, Zhau HE, Chung LW. Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer 2007;109:1279-89. [PMID: 17326044 DOI: 10.1002/cncr.22551] [Cited by in Crossref: 93] [Cited by in F6Publishing: 93] [Article Influence: 6.2] [Reference Citation Analysis]
86 Chiang CK, Sheu ML, Hung KY, Wu KD, Liu SH. Honokiol, a small molecular weight natural product, alleviates experimental mesangial proliferative glomerulonephritis. Kidney Int 2006;70:682-9. [PMID: 16807544 DOI: 10.1038/sj.ki.5001617] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
87 Yance DR, Sagar SM. Targeting angiogenesis with integrative cancer therapies. Integr Cancer Ther. 2006;5:9-29. [PMID: 16484711 DOI: 10.1177/1534735405285562] [Cited by in Crossref: 73] [Cited by in F6Publishing: 83] [Article Influence: 4.6] [Reference Citation Analysis]
88 Ou H, Chou F, Lin T, Yang C, Sheu WH. Protective effects of honokiol against oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cells. Chemico-Biological Interactions 2006;161:1-13. [DOI: 10.1016/j.cbi.2006.02.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
89 Sagar SM, Yance D, Wong RK. Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1. Curr Oncol 2006;13:14-26. [PMID: 17576437] [Reference Citation Analysis]
90 Li L, Lu Q, Shen Y, Hu X. Schisandrin B enhances doxorubicin-induced apoptosis of cancer cells but not normal cells. Biochem Pharmacol. 2006;71:584-595. [PMID: 16405922 DOI: 10.1016/j.bcp.2005.11.026] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 3.9] [Reference Citation Analysis]
91 Tse AK, Wan C, Shen X, Yang M, Fong W. Honokiol inhibits TNF-α-stimulated NF-κB activation and NF-κB-regulated gene expression through suppression of IKK activation. Biochemical Pharmacology 2005;70:1443-57. [DOI: 10.1016/j.bcp.2005.08.011] [Cited by in Crossref: 109] [Cited by in F6Publishing: 112] [Article Influence: 6.4] [Reference Citation Analysis]
92 Battle TE, Arbiser J, Frank DA. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood 2005;106:690-7. [DOI: 10.1182/blood-2004-11-4273] [Cited by in Crossref: 156] [Cited by in F6Publishing: 162] [Article Influence: 9.2] [Reference Citation Analysis]
93 . Literature Watch. Alternative and Complementary Therapies 2005;11:103-4. [DOI: 10.1089/act.2005.11.103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]